Is Q32 Bio Stock a Good Investment?
Q32 Bio Investment Advice | QTTB |
- Examine Q32 Bio's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Q32 Bio's leadership team and their track record. Good management can help Q32 Bio navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Q32 Bio's business and its evolving consumer preferences.
- Compare Q32 Bio's performance and market position to its competitors. Analyze how Q32 Bio is positioned in terms of product offerings, innovation, and market share.
- Check if Q32 Bio pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Q32 Bio's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Q32 Bio stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Q32 Bio is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Q32 Bio Stock
Researching Q32 Bio's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 73.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 7.57. Q32 Bio had not issued any dividends in recent years. The entity had 1:18 split on the 26th of March 2024.
To determine if Q32 Bio is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Q32 Bio's research are outlined below:
| Q32 Bio is way too risky over 90 days horizon | |
| Q32 Bio appears to be risky and price may revert if volatility continues | |
| Q32 Bio has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (47.73 M) with loss before overhead, payroll, taxes, and interest of (48.25 M). | |
| Q32 Bio generates negative cash flow from operations | |
| Q32 Bio has a frail financial position based on the latest SEC disclosures | |
| About 73.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Q32 Bio Appoints Adrien Sipos as Interim Chief Medical Officer QTTB Stock News |
Earnings surprises can significantly impact Q32 Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Q32 Bio's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-08-14 | 2023-06-30 | -0.5 | -0.61 | -0.11 | 22 | ||
2023-11-14 | 2023-09-30 | -0.43 | -0.57 | -0.14 | 32 | ||
2018-08-13 | 2018-06-30 | -0.33 | -0.16 | 0.17 | 51 | ||
2021-05-06 | 2021-03-31 | -0.6138 | -0.36 | 0.2538 | 41 | ||
2025-05-07 | 2025-03-31 | -1.23 | -0.9 | 0.33 | 26 | ||
2025-03-11 | 2024-12-31 | -1.53 | -1.16 | 0.37 | 24 | ||
2024-08-08 | 2024-06-30 | -1.04 | -1.42 | -0.38 | 36 | ||
2018-05-14 | 2018-03-31 | -3.78 | -0.15 | 3.63 | 96 |
Q32 Bio Target Price Consensus
Q32 target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Q32 Bio's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 3 | Buy |
Most Q32 analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Q32 stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Q32 Bio, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationQ32 Bio Target Price Projection
Q32 Bio's current and average target prices are 2.18 and 12.00, respectively. The current price of Q32 Bio is the price at which Q32 Bio is currently trading. On the other hand, Q32 Bio's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Q32 Bio Target Price
Q32 Bio Analyst Ratings
Q32 Bio's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Q32 Bio stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Q32 Bio's financials, market performance, and future outlook by experienced professionals. Q32 Bio's historical ratings below, therefore, can serve as a valuable tool for investors.Q32 Bio's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 26.77 M.Market Cap |
|
Q32 Bio's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.52) | (0.54) | |
| Return On Capital Employed | (0.87) | (0.91) | |
| Return On Assets | (0.52) | (0.54) | |
| Return On Equity | (8.41) | (7.99) |
Determining Q32 Bio's profitability involves analyzing its financial statements and using various financial metrics to determine if Q32 Bio is a good buy. For example, gross profit margin measures Q32 Bio's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Q32 Bio's profitability and make more informed investment decisions.
Please note, the presentation of Q32 Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Q32 Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Q32 Bio's management manipulating its earnings.
Basic technical analysis of Q32 Stock
As of the 21st of July, Q32 Bio owns the market risk adjusted performance of 0.6607, and Coefficient Of Variation of 1507.08. In connection with fundamental indicators, the technical analysis model allows you to check timely technical drivers of Q32 Bio, as well as the relationship between them.Q32 Bio's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Q32 Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Q32 Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Q32 Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Q32 Bio's Outstanding Corporate Bonds
Q32 Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Q32 Bio uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Q32 bonds can be classified according to their maturity, which is the date when Q32 Bio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Understand Q32 Bio's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Q32 Bio's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0714 | |||
| Market Risk Adjusted Performance | 0.6607 | |||
| Mean Deviation | 6.92 | |||
| Semi Deviation | 6.8 | |||
| Downside Deviation | 7.66 | |||
| Coefficient Of Variation | 1507.08 | |||
| Standard Deviation | 16.65 | |||
| Variance | 277.37 | |||
| Information Ratio | 0.0579 | |||
| Jensen Alpha | 0.875 | |||
| Total Risk Alpha | (1.24) | |||
| Sortino Ratio | 0.1258 | |||
| Treynor Ratio | 0.6507 | |||
| Maximum Drawdown | 143.55 | |||
| Value At Risk | (9.63) | |||
| Potential Upside | 8.93 | |||
| Downside Variance | 58.74 | |||
| Semi Variance | 46.2 | |||
| Expected Short fall | (9.20) | |||
| Skewness | 5.76 | |||
| Kurtosis | 40.9 |
| Risk Adjusted Performance | 0.0714 | |||
| Market Risk Adjusted Performance | 0.6607 | |||
| Mean Deviation | 6.92 | |||
| Semi Deviation | 6.8 | |||
| Downside Deviation | 7.66 | |||
| Coefficient Of Variation | 1507.08 | |||
| Standard Deviation | 16.65 | |||
| Variance | 277.37 | |||
| Information Ratio | 0.0579 | |||
| Jensen Alpha | 0.875 | |||
| Total Risk Alpha | (1.24) | |||
| Sortino Ratio | 0.1258 | |||
| Treynor Ratio | 0.6507 | |||
| Maximum Drawdown | 143.55 | |||
| Value At Risk | (9.63) | |||
| Potential Upside | 8.93 | |||
| Downside Variance | 58.74 | |||
| Semi Variance | 46.2 | |||
| Expected Short fall | (9.20) | |||
| Skewness | 5.76 | |||
| Kurtosis | 40.9 |
Consider Q32 Bio's intraday indicators
Q32 Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Q32 Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 20431.71 | |||
| Daily Balance Of Power | (0.06) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 2.22 | |||
| Day Typical Price | 2.2 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.01) |
Q32 Stock media impact
There is far too much social signal, news, headlines, and media speculation about Q32 Bio that are available to investors today. This information is accessible both publicly - through Q32 Bio's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Q32-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Q32 Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Q32 Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Q32 Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Q32 Bio alpha.
Q32 Bio Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Q32 Bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Q32 Bio Corporate Management
| Saul Fink | Chief Officer | Profile | |
| Kathryn MBA | Manufacturing Chemistry | Profile | |
| Adrien Sipos | Interim Officer | Profile | |
| Lee MBA | Chief Officer | Profile | |
| Maria MPH | Executive Operations | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Q32 Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For information on how to trade Q32 Stock refer to our How to Trade Q32 Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Q32 Bio. If investors know Q32 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Q32 Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Q32 Bio is measured differently than its book value, which is the value of Q32 that is recorded on the company's balance sheet. Investors also form their own opinion of Q32 Bio's value that differs from its market value or its book value, called intrinsic value, which is Q32 Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Q32 Bio's market value can be influenced by many factors that don't directly affect Q32 Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Q32 Bio's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Q32 Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Q32 Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.